Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q5SX
|
|||
| Former ID |
DIB004007
|
|||
| Drug Name |
HMaxi-K
|
|||
| Indication | Overactive bladder [ICD-11: GC50.0; ICD-10: N32.8] | Phase 1 | [1] | |
| Company |
Ion channel innovations
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01870037) Phase 1 Study in Subjects With OAB Assessing the Safety and Activity of 2 Doses of hMaxi-K Gene Transfer Injected Directly Into the Bladder Wall. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.